STIFF PERSON SYNDROME
Clinical trials for STIFF PERSON SYNDROME explained in plain language.
Never miss a new study
Get alerted when new STIFF PERSON SYNDROME trials appear
Sign up with your email to follow new studies for STIFF PERSON SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on lupus and scleroderma in early trial
Disease control ENROLLING_BY_INVITATIONThis early-phase study tests a new treatment called Prula-cel for people with autoimmune diseases like lupus, scleroderma, and vasculitis. Prula-cel uses specially engineered immune cells from a donor to target and attack faulty B cells that drive the disease. The main goals are …
Matched conditions: STIFF PERSON SYNDROME
Phase: PHASE1 • Sponsor: Adicet Therapeutics • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
Could a stem cell transplant stop immune attacks on the brain?
Disease control OngoingThis study tests a strong chemotherapy combination followed by a stem cell transplant to treat autoimmune neurologic diseases like multiple sclerosis and stiff person syndrome. The goal is to weaken the immune system so it stops attacking the nervous system. About 53 adults whose…
Matched conditions: STIFF PERSON SYNDROME
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC